Last $63.96 USD
Change Today +0.35 / 0.55%
Volume 308.6K
CRL On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Samuel O. Thier MD

Former Independent Director and Member of Corporate Governance & Nominating Committee, Charles River Laboratories International, Inc.
AgeTotal Calculated CompensationThis person is connected to 134 board members in 5 different organizations across 5 different industries.

See Board Relationships
76--

Background*

Dr. Samuel O. Thier, MD serves as a Professor of Medicine and Health Care Policy, Emeritus at Harvard Medical School, Massachusetts General Hospital. Dr. Thier served as the Chief Executive Officer of Partners HealthCare System, Inc. from July 1, 1996 to December 1, 2002. Previously, Dr. Thier served as the President of The Massachusetts General Hospital from 1994 to 1997 and President of Brandeis University from 1991 to 1994. He served as the President of the Institute ...

Read Full Background

Corporate Headquarters*

251 Ballardvale Street
Wilmington, Massachusetts 01887

United States

Phone: 781-222-6000
Fax: --

Board Members Memberships*

Director and Member of Science and Technology Committee
1994-2010
Former Lead Director, Chairman of Committee on Corporate Governance, Member of Research Committee and Member of Committee on Public Policy & Social Responsibility
2000-2013
Former Independent Director and Member of Corporate Governance & Nominating Committee

Education*

MD
State University of New York in Syracuse

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRL:US $63.96 USD +0.35

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.6M
Leonard Bell M.D.Co-Founder, Chairman of the Board and Chief Executive Officer
Alexion Pharmaceuticals, Inc.
$1.2M
Mark C. Rohr Chairman of the Board, Chief Executive Officer and President
Celanese Corporation
$1.0M
Shigenobu Maekawa President and Representative Director
Nippon Shinyaku Co. Ltd.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHARLES RIVER LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.